Sort
21,281 grants matching “influenza”
Systems Approach to Immunity and Inflammation
$6,339,499Richard J Ulevitch · Scripps Research Institute, The · U19 · FY2014 · AI
Centers of Excellence for Influenza Research and Surveillance
$6,333,252Richard Compans · Emory University · N01 · FY2013 · AI
GH21-003, Advancing Public Health Research in Kenya
$6,329,348M Kariuki Njenga · Washington State University · U01 · FY2021 · GH
Systems Approach to Immunity and Inflammation
$6,324,437Richard J Ulevitch · Scripps Research Institute, The · U19 · FY2015 · AI
Establishment of a Vaccine Pilot Plant
$6,292,469Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2015 · AI
GH21-003, Advancing Public Health Research in Kenya
$6,288,488M Kariuki Njenga · Washington State University · U01 · FY2025 · GH
Establishment of a Vaccine Pilot Plant
$6,281,133Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2014 · AI
Establishment of a Vaccine Pilot Plant
$6,281,133Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2013 · AI
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
$6,280,404Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2021 · AI
Antiviral Drug Discovery and Development Center - Overall
$6,270,702Richard J. Whitley · University Of Alabama At Birmingham · U19 · FY2014 · AI
Minnesota Center of Excellence for Influenza Research and Surveillance
$6,268,500University Of Minnesota · N01 · FY2008 · AI
DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity
$6,237,659Paul Glyndwr Thomas · St. Jude Children'S Research Hospital · U01 · FY2024 · AI
The Michigan Infectious Disease Genomics (MIDGE) Center
$6,233,451Adam Lauring · University Of Michigan At Ann Arbor · U19 · FY2024 · AI
RADX TECH XTRAVA, INC. - SPERA COVID-19 AG TESTRAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT #5834 XTRAVA, INC.
$6,207,000Sameh Sarhan · Xtrava, Inc. · N02 · FY2021 · HL
Systems Approach to Immunity and Inflammation
$6,166,888Richard J Ulevitch · Scripps Research Institute, The · U19 · FY2013 · AI
Task 13/C26 Challenge Models and Assays to Develop Influenza Vaccines
$6,158,997Judy Britt · Southern Research Institute · N01 · FY2009 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
$6,141,359Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2023 · AI
Adjuvant development in the context of seasonal and pandemic influenza
$6,116,145University Of Montana · N01 · FY2018 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$6,113,687David S Stephens · Emory University · UM1 · FY2023 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$6,111,537David S Stephens · Emory University · UM1 · FY2024 · AI
Center for Research on Influenza Pathogenesis
$6,100,106Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2009 · AI
Centers of Excellence for Influenza Research and Surveillance
$6,091,103Adolpho Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2011 · AI
MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESOURCE REPOSITORY (MID-BRR)
$6,075,000James McArdle · American Type Culture Collection · N01 · FY2011 · AI
DEVELOPMENT OF THERAPEUTIC MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES
$6,071,737Wilson Russell · Autoimmune Technologies, Llc · N01 · FY2014 · AI
An Inactivated Influenza Nasal Powder Vaccine
$6,061,068Delsite Biotechnologies, Inc. · UC1 · FY2004 · AI